Pavicevic Sandra, Uluk Deniz, Reichelt Sophie, Fikatas Panagiotis, Globke Brigitta, Raschzok Nathanael, Schmelzle Moritz, Öllinger Robert, Schöning Wenzel, Eurich Dennis, Pratschke Johann, Lurje Georg
Department of Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Artif Organs. 2022 Feb;46(2):306-311. doi: 10.1111/aor.14103. Epub 2021 Nov 7.
In times of critical organ shortage, poor organ pool utilization and increased use of extended-criteria donor (ECD) allografts remain a major problem. Hypothermic oxygenated machine perfusion (HOPE) has emerged as a promising and feasible strategy in ECD liver transplantation (LT). However, potential safety limits regarding the duration of perfusion are yet to be explored. Besides marginal allograft quality (steatosis), prolonged cold ischemia time remains the most important factor for a high number of liver allografts being declined for transplantation.
Two ECD-allografts were each allocated to two recipients, who proved to be unsuitable to receive the assigned allograft upon arrival at the transplant center. The organs were reallocated by Eurotransplant and accepted by our center for two different backup patients. During that time, HOPE was commenced and continued until the recipient hepatectomy was completed. Postoperative allograft function was assessed by serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), bilirubin, and International Normalized Ratio. Incidence of early allograft dysfunction (EAD), postoperative complications, and length of hospital stay were analyzed.
HOPE was applied for 4 h 35 min and 4 h 20 min, resulting in a total cold preservation time of 17 h 29 min and 15 h 20 min, respectively. Both recipients displayed decreasing serum transaminases and bilirubin levels postoperatively. No EAD or major postoperative complications occurred in either patient. Serum ALT and AST levels were within the normal range at discharge.
Extended HOPE enables the safe extension of preservation time for up to 18 h in human LT. End-ischemic HOPE may significantly improve organ pool utilization, while simultaneously facilitating operating room logistics and preventing organ injury.
在关键器官短缺时期,器官库利用率低下以及扩大标准供体(ECD)同种异体移植物使用增加仍是一个主要问题。低温氧合机器灌注(HOPE)已成为ECD肝移植(LT)中一种有前景且可行的策略。然而,关于灌注持续时间的潜在安全限制尚待探索。除了同种异体移植物质量欠佳(脂肪变性)外,延长的冷缺血时间仍然是大量肝同种异体移植物被拒绝用于移植的最重要因素。
两个ECD同种异体移植物分别分配给两名受者,但这两名受者在抵达移植中心时被证明不适合接受分配的同种异体移植物。这些器官由欧洲移植组织重新分配,并被我们中心接受用于两名不同的候补患者。在此期间,开始并持续进行HOPE,直至受者肝切除术完成。通过血清丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、胆红素水平及国际标准化比值评估术后同种异体移植物功能。分析早期同种异体移植物功能障碍(EAD)的发生率、术后并发症及住院时间。
HOPE分别应用了4小时35分钟和4小时20分钟,导致总的冷保存时间分别为17小时29分钟和15小时20分钟。两名受者术后血清转氨酶和胆红素水平均下降。两名患者均未发生EAD或重大术后并发症。出院时血清ALT和AST水平在正常范围内。
延长的HOPE可使人LT中的保存时间安全延长至18小时。缺血末期HOPE可显著提高器官库利用率,同时便于手术室安排并防止器官损伤。